Zhe Nie

1.0k citations

23 papers · 736 indexed · h-index 12

Molecular Biology
Organic Chemistry top 10%
Oncology
Pharmacology
Computational Theory and Mathematics top 10%

Co-authors: Stephen A. Margosiak Robert J. Almassy Kraig M. Yager Krzysztof Appelt April M. Averill V. I. Nikulin Ying Su K.S. Gajiwala
Topics: Chronic Lymphocytic Leukemia Research (6 papers)Biochemical and Molecular Research (5 papers)Chemical Synthesis and Analysis (3 papers)
Cited by: Organic Chemistry Molecular Biology Molecular Medicine
Journals: Blood Biochemistry FEBS Letters
Partner nations: United States Switzerland

In The Last Decade

Zhe Nie

23 papers receiving 722 citations

Peers

Countries citing papers authored by Zhe Nie

Since Specialization

Citations

This map shows the geographic impact of Zhe Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe Nie more than expected).

Fields of papers citing papers by Zhe Nie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhe Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe Nie. The network helps show where Zhe Nie may publish in the future.

Co-authorship network of co-authors of Zhe Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Zhe Nie. A scholar is included among the top collaborators of Zhe Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhe Nie. Zhe Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury 2024 ·Journal of Medicinal Chemistry ·H. Rachel Lagiakos,(unknown),(unknown),Éric Therrien,(unknown),Mitsunori Kato,Mats Svensson,(unknown),(unknown),Markus K. Dahlgren,(unknown),Karen H. Dingley,(unknown),Zhijian Liu,(unknown),(unknown),R.J. Skene,Zhe Nie	4
2	SGR‐1505‐101: A PHASE 1, OPEN‐LABEL, MULTICENTER, DOSE‐ESCALATION STUDY OF SGR‐1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B‐CELL MALIGNANCIES 2023 ·Hematological Oncology ·Adam J. Olszewski,Douglas Kahn,Byunggil Yoo,Zhe Nie,Goran Krilov,(unknown),(unknown),(unknown),Yin Wu,Karen Akinsanya	1
3	A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, K _p,uu 2023 ·Journal of Chemical Information and Modeling ·(unknown),Mats Svensson,Mitsunori Kato,Karen H. Dingley,Jackson Chief Elk,Zhe Nie,(unknown),(unknown),H. Rachel Lagiakos,(unknown),Éric Therrien	11
4	A Phase 1, Open-Label, Multicenter, Dose-Escalation Study of Sgr-1505 As Monotherapy in Subjects with Mature B-Cell Malignancies 2023 ·Blood ·Adam J. Olszewski,David Kahn,Byong Kwon Yoo,(unknown),(unknown),Edgar Schuck,Zhe Nie,Goran Krilov,D. Hamish Wright,(unknown),Jean E. Lachowicz,Karen Akinsanya,Yin Wu	3
5	Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Zhe Nie,Lihong Shi,Chon Lai,Christophe Severin,Jiangchun Xu,(unknown),Ryan Stansfield,(unknown),Toufike Kanouni,James M. Veal,Jeffrey A. Stafford,Young K. Chen	12
6	Structure-based design and discovery of potent and selective KDM5 inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Zhe Nie,Lihong Shi,Chon Lai,Shawn M. O’Connell,Jiangchun Xu,Ryan Stansfield,David J. Hosfield,James M. Veal,Jeffrey A. Stafford	32
7	TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens 2011 ·Molecular Cancer Therapeutics ·(unknown),Kohei Honda,(unknown),Hitoshi Miyashita,(unknown),Saomi Murai,Noriko Uchiyama,Maki Hasegawa,Tomohiro Kawamoto,Takashi Sato,Takashi Ichikawa,(unknown),Zhe Nie,(unknown),Johnny Yang,Keisuke Kuida,Erik Kupperman	64
8	Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzyme 2009 ·FEBS Letters ·K.S. Gajiwala,Stephen A. Margosiak,(unknown),(unknown),Ying Su,Zhe Nie,Krzysztof Appelt	50
9	Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhe Nie,(unknown),(unknown),Stephen A. Margosiak,Robert J. Almassy,(unknown),April M. Averill,Kraig M. Yager,(unknown)	82
10	Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhe Nie,(unknown),(unknown),Stephen A. Margosiak,(unknown),April M. Averill,Robert J. Almassy,(unknown)	80
11	Synthesis and Monoamine Transporter Binding Properties of 2,3-Cyclo Analogues of 3β-(4‘-Aminophenyl)-2β-tropanemethanol 2006 ·Journal of Medicinal Chemistry ·F. Ivy Carroll,Bruce E. Blough,Xiaodong Huang,Zhe Nie,S. Wayne Mascarella,Jeffrey R. Deschamps,Hernán A. Navarro	2
12	Structure-Based Design, Synthesis, and Study of Potent Inhibitors of β-Ketoacyl-acyl Carrier Protein Synthase III as Potential Antimicrobial Agents 2005 ·Journal of Medicinal Chemistry ·Zhe Nie,(unknown),(unknown),Ying Su,Stephen A. Margosiak,K.S. Gajiwala,(unknown),V. I. Nikulin,Kraig M. Yager,Krzysztof Appelt,(unknown)	83
13	Synthesis and Monoamine Transporter Binding Properties of 3β-(3‘,4‘-Disubstituted phenyl)tropane-2β-carboxylic Acid Methyl Esters 2005 ·Journal of Medicinal Chemistry ·F. Ivy Carroll,Bruce E. Blough,Zhe Nie,Michael J. Kuhar,Leonard L. Howell,Hernán A. Navarro	13
14	Structure-based design, synthesis, and antimicrobial activity of purine derived SAH/MTA nucleosidase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Zhe Nie,Stephen A. Margosiak,(unknown),Victoria A. Feher,Robert J. Almassy,Krzysztof Appelt,Kraig M. Yager	22
15	Modification of Escherichia coli Thymidylate Synthase at Tyrosine-94 by 5-Imidazolylpropynyl-2‘-deoxyuridine 5‘-Monophosphate 2003 ·Biochemistry ·Ruth L. Saxl,James Reston,Zhe Nie,Thomas I. Kalman,Frank Maley	8
16	Structure-Based Design, Synthesis, and Antimicrobial Activity of Indazole-Derived SAH/MTA Nucleosidase Inhibitors 2003 ·Journal of Medicinal Chemistry ·Xiaoming Li,(unknown),Victoria A. Feher,Mitra Khalili,Zhe Nie,Stephen A. Margosiak,V. I. Nikulin,James C. Levin,Kelly G. Sprankle,(unknown),Robert J. Almassy,Krzysztof Appelt,Kraig M. Yager	141
17	Synthesis and Transporter Binding Properties of 3β-[4‘-(Phenylalkyl, -phenylalkenyl, and -phenylalkynl)phenyl]tropane-2β-carboxylic Acid Methyl Esters: Evidence of a Remote Phenyl Binding Domain on the Dopamine Transporter 2002 ·Journal of Medicinal Chemistry ·Bruce E. Blough,(unknown),Zhe Nie,Hernán A. Navarro,Michael J. Kuhar,F. Ivy Carroll	14
18	5-PROPYNYLPYRIMIDINE NUCLEOSIDE DERIVATIVES: RATIONALLY DESIGNED MECHANISM-BASED INACTIVATORS OF THYMIDYLATE SYNTHASE 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Thomas I. Kalman,Zhe Nie,(unknown)	7
19	Rational Design of Selective Antimetabolites of DNA-Thymine Biosynthesis: 5-Propynylpyrimidine Nucleoside Derivatives 2000 ·Nucleosides Nucleotides & Nucleic Acids ·Thomas I. Kalman,Zhe Nie	6
20	Mechanism-based inactivation of thymidylate synthase by 5-(3-fluoropropyn-1-yl)-2′-deoxyuridine 5′-phosphate 2000 ·Bioorganic & Medicinal Chemistry Letters ·Thomas I. Kalman,Zhe Nie,(unknown)	5

About Zhe Nie

Zhe Nie is a scholar working on Genetics, Physiology and Molecular Biology, having authored 23 papers that have together received 736 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Biochemical and Molecular Research (5 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Organic Chemistry (308 citations), Molecular Biology (407 citations) and Molecular Medicine (26 citations). Zhe Nie has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Stephen A. Margosiak, Robert J. Almassy, Kraig M. Yager, Krzysztof Appelt, April M. Averill, V. I. Nikulin, Ying Su, K.S. Gajiwala, Victoria A. Feher and James C. Levin. Their work appears in journals such as Blood, Biochemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact